Reconstitution of the peripheral B lymphocyte compartment in patients with ANCA-associated vasculitides treated with rituximab for relapsing or refractory disease-Reference-Cited by-同舟云学术

Reconstitution of the peripheral B lymphocyte compartment in patients with ANCA-associated vasculitides treated with rituximab for relapsing or refractory disease

Published:2014-05-06 Issue:6 Volume:47 Page:401-408
ISSN:0891-6934
Container-title:Autoimmunity
language:en
Short-container-title:Autoimmunity

Author:

Venhoff Nils,Niessen Lena,Kreuzaler Matthias,Rolink Antonius G.,Hässler Fabian,Rizzi Marta,Voll Reinhard E.,Thiel Jens

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

http://www.tandfonline.com/doi/pdf/10.3109/08916934.2014.914174

Reference42 articles.

1. ANCA-stimulated neutrophils release BLyS and promote B cell survival: a clinically relevant cellular process

2. B cells participate in tolerance and autoimmunity through cytokine production

3. BAFF is elevated in serum of patients with Wegener's granulomatosis

4. Excess BAFF Rescues Self-Reactive B Cells from Peripheral Deletion and Allows Them to Enter Forbidden Follicular and Marginal Zone Niches

5. Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defects in B-lymphopoiesis and B-cell maturation underlie prolonged B-cell depletion in ANCA-associated vasculitis;Annals of the Rheumatic Diseases;2024-06-08

2. Sustained post-rituximab B-cell depletion is common in ANCA-associated vasculitis and is affected by sex and renal function;Nephrology Dialysis Transplantation;2023-09-06

3. Longitudinal monitoring of circulating immune cell phenotypes in anti-neutrophil cytoplasmic antibody-associated vasculitis;Autoimmunity Reviews;2023-03

4. The Efficacy and Safety of Rituximab in ANCA-Associated Vasculitis: A Systematic Review;Biology;2022-12-06

5. Rituximab Therapy for Adults with Nephrotic Syndromes: Standard Schedules or B Cell-Targeted Therapy?;Journal of Clinical Medicine;2021-12-13